Work

Faculty Opinions recommendation of MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Year: 2007

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.1084903.537843

Author: William Kaelin

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4234791182

Cites:

Cited by:

Related to: 10